New West Genetics
Daphne Preuss is an accomplished professional with extensive experience in the biotechnology and life sciences sectors. As the owner of Catalytical, LLC, and holding significant leadership positions, including Chief Financial Officer at RedLeaf Biologics, Inc. and Chief Business Officer at SOLASTA Bio, Daphne has demonstrated expertise in financial management and business development. Additionally, as a partner at Natáur LLC and a board member at New West Genetics, Daphne contributes strategic insights to various ventures. Educationally, Daphne Preuss earned a PhD in Biology from the Massachusetts Institute of Technology and a B.S. in Chemistry from the University of Denver.
This person is not in any offices
New West Genetics
New West Genetics is developing and improving Industrial hemp genetics for adaptation to various regions of the United States. They combine traditional breeding with modern genomics to create stable genetics, optimized traits across industries, and varieties adapted for large-scale production.